NCT03660475View on ClinicalTrials.gov

Effect of Topical Naltrexone Ophthalmic Solution on the Signs and Symptoms of Dry Eye in Diabetic Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 31, 2018

Primary Completion Date

November 1, 2018

Study Completion Date

November 15, 2018

Conditions
Dry Eye Disease
Interventions
DRUG

Naltrexone

naltrexone formulated as ophthalmic solution

DRUG

Placebos

Placebo ophthalmic solution

Trial Locations (1)

38119

Total Eye Care, Memphis

All Listed Sponsors
lead

Sassani, Joseph S., MD, MHA

INDIV

NCT03660475 - Effect of Topical Naltrexone Ophthalmic Solution on the Signs and Symptoms of Dry Eye in Diabetic Subjects | Biotech Hunter | Biotech Hunter